Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.60
-0.25 (-3.65%)
Aug 14, 2025, 2:09 PM - Market open
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 45 employees as of December 31, 2024. The number of employees decreased by 31 or -40.79% compared to the previous year.
Employees
45
Change (1Y)
-31
Growth (1Y)
-40.79%
Revenue / Employee
n/a
Profits / Employee
-$1,627,000
Market Cap
357.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FULC News
- 5 days ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025 - GlobeNewsWire
- 16 days ago - Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease - GlobeNewsWire
- 16 days ago - Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics to Present at Upcoming Medical Meetings - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics to Participate in Upcoming May Conferences - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics, Inc. (FULC) Q1 2025 Earnings Call Transcript - Seeking Alpha